Amorphous and Crystalline Particulates: Challenges and Perspectives in Drug Delivery

Title:Amorphous and Crystalline Particulates: Challenges and Perspectives in Drug Delivery

Volume: 23 Issue: 3

Author(s): Hisham Al-Obaidi, Mridul Majumder and Fiza Bari

Affiliation:

Keywords: Solid dispersions, milling, surfactants, saturation solubility, thermal analysis, co-crystals.

Abstract: Crystalline and amorphous dispersions have been the focus of academic and industrial research due to their potential role in formulating poorly water-soluble drugs. This review looks at the progress made starting with crystalline carriers in the form of eutectics moving towards more complex crystalline mixtures. It also covers using glassy polymers to maintain the drug as amorphous exhibiting higher energy and entropy. However, the amorphous form tends to recrystallize on storage, which limits the benefits of this approach. Specific interactions between the drug and the polymer may retard this spontaneous conversion of the amorphous drug. Some studies have shown that it is possible to maintain the drug in the amorphous form for extended periods of time. For the drug and the polymer to form a stable mixture they have to be miscible on a molecular basis. Another form of solid dispersions is pharmaceutical co-crystals, for which research has focused on understanding the chemistry, crystal engineering and physico-chemical properties. USFDA has issued a guidance in April 2013 suggesting that the co-crystals as a pharmaceutical product may be a reality; but just not yet! While some of the research is still oriented towards application of these carriers, understanding the mechanism by which drug-carrier miscibility occurs is also covered. Within this context is the use of thermodynamic models such as Flory-Huggins model with some examples of studies used to predict miscibility.

Cite this article as:

Al-Obaidi Hisham, Majumder Mridul and Bari Fiza, Amorphous and Crystalline Particulates: Challenges and Perspectives in Drug Delivery, Current Pharmaceutical Design 2017; 23 (3) . https://dx.doi.org/10.2174/1381612822666161107162109